Charles River Laboratories (CRL) vs peers
CRL's P/E is not meaningful or is unavailable. Choose another measure to compare peers.
Life Sciences Tools & Services. Updated .
| Stock | P/E | Own 5-year rank |
|---|---|---|
| CRLCharles River Laboratories | Unavailable | Unranked |
| TECHBio-Techne | 63.2x | 50% |
| DHRDanaher Corporation | 41.5x | 58% |
| MTDMettler Toledo | 37.8x | 70% |
| TMOThermo Fisher Scientific | 37.3x | 92% |
| AAgilent Technologies | 35.1x | 87% |
| IQVIQVIA | 34.3x | 61% |
How to read this comparison
Up to eight covered companies in the same industry, largest market value first.
P/E divides the share price by earnings per share from the previous twelve months. The middle peer reading excludes CRL and unavailable values.
Own 5-year rank compares each stock with its available weekly readings within the last five years. At least 26 usable weeks are required. A rank of 20% means its current multiple is above 20% of its past readings. It is not a rank against the other stocks in this table.
Dates show data updates; the latest available weekly observation can differ between stocks. Different growth rates, margins and financial risks can explain different multiples. Missing or non-positive denominators are left unranked.